Detomidine

Detomidine

SCHEMBL247340

Cc1cccc(Cc2c[nH]cn2)c1C

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
SLC6A3 Q01959 2/20 0.34
GPR84 Q9NQS5 1/20 0.34
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
CDC7 O00311 1/20 0.33
ROCK2 O75116 1/20 0.33
MAP4K4 O95819 1/20 0.33
PIM1 P11309 1/20 0.33
PRKACA P17612 1/20 0.33
CDK2 P24941 1/20 0.33
GSK3B P49841 1/20 0.33
HIPK2 Q9H2X6 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
HTR1B P28222 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
POLB P06746 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Detomidine SCHEMBL7087060 1.00 ALDH1A1 (0.35) ALDH1A1SLC6A2SLC6A4SLC6A3GPR84
Detomidine SCHEMBL203174 0.98 ALDH1A1 (0.34) ALDH1A1SLC6A2SLC6A4SLC6A3GPR84
Detomidine SCHEMBL21618409 0.98 ALDH1A1 (0.34) ALDH1A1SLC6A2SLC6A4SLC6A3GPR84
Detomidine SCHEMBL20362222 0.98 ALDH1A1 (0.34) ALDH1A1SLC6A2SLC6A4SLC6A3GPR84
Detomidine SCHEMBL28676651 0.98 ALDH1A1 (0.34) ALDH1A1SLC6A2SLC6A4SLC6A3GPR84
Detomidine SCHEMBL21624996 0.97 SLC6A2 (0.33) ALDH1A1SLC6A2SLC6A4SLC6A3GPR84
Detomidine SCHEMBL20362216 0.91 ESR1 (0.33) ALDH1A1SLC6A2SLC6A4SLC6A3ESR1
Detomidine SCHEMBL20362221 0.91 ESR1 (0.33) ALDH1A1SLC6A2SLC6A4SLC6A3ESR1
Detomidine SCHEMBL28311140 0.91 KDM4C (0.36) SLC6A2SLC6A4SLC6A3ESR1ESR2
Detomidine SCHEMBL20362214 0.90 KDM4C (0.38) ALDH1A1PIM1HPGDP2RX7ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2677 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4704826-A1 COMPOSITIONS AND METHODS FOR TREATING POST-TRAUMATIC STRESS DISORDER Yale University (US) 2026-03-11 EP claimed
EP-4704839-A2 IMIDAZOLE CONTAINING COMPOUNDS, DERIVATIVES THEREFORE, AND USES THEREOF ALPHERABIO LLC (US) 2026-03-11 EP claimed
US-12501899-B2 Mite infestation treatment VETO-PHARMA (FR) 2025-12-23 US claimed
EP-4661680-A1 COMPOSITION FOR CONTROLLING MITE INFESTATION Veto-Pharma (FR) 2025-12-17 EP claimed
US-12472158-B2 Methods of treating trigeminal nerve pain VANDERBILT UNIVERSITY (US) 2025-11-18 US claimed
US-20250288558-A1 THERAPEUTIC FOR SPINAL CORD INJURY TO INDUCE HYPOTHERMIA THE TRUSTEES OF INDIANA UNIVERSITY 2025-09-18 US claimed
US-20250213647-A1 CHEMOKINE RECEPTORS AND ALPHA1 ADRENERGIC RECEPTORS/VASOPRESSIN RECEPTORS 1A HETEROMERS AS DRUG TARGETS FOR DISEASE UNIVERSITY OF SOUTH FLORIDA 2025-07-03 US claimed
US-20250186401-A1 COMBINATORIAL ACTIVATION OF GABA(B) AND A2 ADRENERGIC RECEPTORS PROVIDES RELIEF FROM STRESS INDUCED DEPRESSION UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2025-06-12 US claimed
WO-2025080559-A1 METHODS AND COMPOSITIONS FOR TREATING DRUG OVERDOSE ENALARE THERAPEUTICS INC. (US) 2025-04-17 WO claimed
US-20250114370-A1 METHODS AND COMPOSITIONS FOR TREATING DRUG OVERDOSE ENALARE THERAPEUTICS INC (US) 2025-04-10 US claimed
EP-0573581-A4 COMPOSITIONS AND METHODS OF TREATMENT OF SYMPATHETICALLY MAINTAINED PAIN ARC 1 INC (US) 1994-06-29 EP claimed
WO-1993025199-A1 ALPHA-2-ADRENERGIC AGONISTS FOR TREATING PRESBYOPIA TELOR OPHTHALMIC PHARMACEUTICALS, INC. (US) 1993-12-23 WO claimed
EP-0573581-A1 COMPOSITIONS AND METHODS OF TREATMENT OF SYMPATHETICALLY MAINTAINED PAIN ARC 1, Inc. (US) 1993-12-15 EP claimed
EP-0424059-B1 USE OF SUSTITUTED IMIDAZOLES FOR THE MANUFACTURE OF AN ANALGESIC ORION-YHTYMÀ„ OY (FI) 1993-03-03 EP claimed
WO-1992014453-A1 COMPOSITIONS AND METHODS OF TREATMENT OF SYMPATHETICALLY MAINTAINED PAIN ARC 1, INC. (US) 1992-09-03 WO claimed
EP-0424059-A1 Use of sustituted imidazoles for the manufacture of an analgesic ORION-YHTYMÀ„ OY (FI) 1991-04-24 EP claimed
EP-0138358-A1 The preparation and use of 2-[2-(1,4-benzodioxanyl)]-2-imidazoline in therapy Farmos-Yhtyma Oy (FI) 1985-04-24 EP claimed
EP-0024829-B1 4-BENZYL- AND 4-BENZOYLIMIDAZOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME Farmos-Yhtyma Oy (FI) 1984-04-25 EP claimed
US-4443466-A DIURETICS, SEDATIVES, ANALGESICS Farmos-Yhtyma OY (Farmos Group Ltd.) (FI) 1984-04-17 US claimed
EP-0024829-A1 4-Benzyl- and 4-benzoylimidazole derivatives, processes for their preparation and pharmaceutical compositions comprising the same Farmos-Yhtyma Oy (FI) 1981-03-11 EP claimed